Cochlear Ltd (COH): 2H14 sales better than expected, but Cochlear implant unit growth still missing

Bell Potter

Stockbroker

Cochlear Ltd (COH): 2H14 sales better than expected, but Cochlear implant unit growth still missing. COH's sales were ahead of our expectations by around 3%, EBIT by around 12% and NPAT by around 12%. This was a credible result after the disappointing 1H14, although we note underlying EBIT was still down 16% for FY14 and underlying NPAT down 17%. Cochlear implant unit growth is still missing -sales declined 3%. Ex-China tender, CI unit sales increased 1%. We think market growth is around 5-10%, and likely towards low-end of this range, implying COH has lost global market share. However, market share appears to be stabilising as 2H14 Cochlear implant unit sales were up 3% ex-China, following a 1% decline in 1H14. Whether this will keep improving in FY15 remains to be seen, particularly given ongoing competitive pressures. Our recommendation is a Sell.


Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.